MariMed - MRMD Stock Forecast, Price & News

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for MariMed in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" MRMD shares.
View MRMD analyst ratings or view top-rated stocks.

1 brokerages have issued 1-year target prices for MariMed's stock. Their MRMD share price forecasts range from $0.85 to $0.85. On average, they predict the company's share price to reach $0.85 in the next year. This suggests a possible upside of 123.7% from the stock's current price.
View analysts price targets for MRMD or view top-rated stocks among Wall Street analysts.

MariMed's stock was trading at $0.3562 at the beginning of the year. Since then, MRMD stock has increased by 6.7% and is now trading at $0.38.
View the best growth stocks for 2023 here.

MariMed saw a increase in short interest in March. As of March 15th, there was short interest totaling 28,600 shares, an increase of 140.3% from the February 28th total of 11,900 shares. Based on an average daily volume of 428,300 shares, the days-to-cover ratio is presently 0.1 days.
View MariMed's Short Interest.

MariMed Inc. (OTCMKTS:MRMD) announced its quarterly earnings data on Monday, November, 15th. The company reported $0.01 earnings per share (EPS) for the quarter. The firm had revenue of $33.21 million for the quarter. MariMed had a trailing twelve-month return on equity of 27.89% and a net margin of 10.05%.

MariMed updated its FY 2023 earnings guidance on Wednesday, March, 1st. The company provided EPS guidance of for the period. The company issued revenue guidance of $150.00M-, compared to the consensus revenue estimate of $152.80 million.

Based on aggregate information from My MarketBeat watchlists, some companies that other MariMed investors own include KushCo (KSHB), Organigram (OGI), Auxly Cannabis Group (CBWTF), CNBX Pharmaceuticals (CNBX), Supreme Cannabis (SPRWF), Gran Tierra Energy (GTE), Pennsylvania Real Estate Investment Trust (PEI), GB Sciences (GBLX), Medical Marijuana (MJNA) and Smart Cannabis (SCNA).

MariMed trades on the OTCMKTS under the ticker symbol "MRMD."

Shares of MRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MRMD stock can currently be purchased for approximately $0.38.

MariMed (OTCMKTS:MRMD) has a market capitalization of $128.99 million and generates $134.01 million in revenue each year. The company earns $13.47 million in net income (profit) each year or $0.03 on an earnings per share basis.

The company employs 260 workers across the globe.

MariMed's mailing address is 11 ROYAL ROAD, BROOKLINE MA, 02445. The official website for the company is marimedadvisors.com. The company can be reached via phone at (617) 795-5140 or via email at ir@mattio.com.